Abstract

ROSANOVA, María T et al. Efficacy and safety of caspofungin in children: systematic review and meta-analysis. Arch. argent. pediatr. [online]. 2016, vol.114, n.4, pp.305-312. ISSN 0325-0075.  http://dx.doi.org/10.5546/aap.2016.305.

Invasive fungal infections are a significant cause of morbidity and mortality in children. Caspofungin is an echinocandin used as an alternative treatment in the prevention and/or treatment of certain invasive fungal infections in children, although compared to the standard treatment there is little evidence on its efficacy and safety. Objectives. To evaluate the efficacy and safety of caspofungin compared with other antifungal drugs for the prevention and/or treatment of invasive fungal infections in children. Material and methods. The objective of the initial search strategy was to identify randomized controlled studies of acceptable methodological quality (Jadad scale >3), through the key word "caspofungin", conducted in patients with an age range from 0 to 18 years old. Results. Only 3 publications met the inclusion criteria. Two of them were studies conducted in children and one in newborn infants. A higher incidence of adverse events was not documented for caspofungin and its efficacy was not different from that of other antifungal drugs (typical RR 1.47; CI 95%: 0.78-2.79). Conclusions. This systematic review suggests that caspofungin could be considered as an alternative drug in children for the prevention and treatment of invasive fungal infections. However, given the small number of existing publications, more studies are required to reach definite conclusions.

Keywords : Caspofungin; Mycosis; Efficacy; Child; Safety.

        · abstract in Spanish     · text in English | Spanish     · English ( pdf ) | Spanish ( pdf )